Cdk9 phosphorylates p53 on serine 392 independently of CKII
暂无分享,去创建一个
A. Giordano | K. Khalili | P. Claudio | S. Amini | M. White | B. Sawaya | J. Sheffield | M. Ghafouri | M. Safak | Jianqi Cui | Chiara Mariano
[1] L. Johnson,et al. Exploiting structural principles to design cyclin-dependent kinase inhibitors. , 2005, Biochimica et biophysica acta.
[2] M. Shah,et al. Targeting the cell cycle: a new approach to cancer therapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] K. Khalili,et al. p73 Interacts with Human Immunodeficiency Virus Type 1 Tat in Astrocytic Cells and Prevents Its Acetylation on Lysine 28 , 2005, Molecular and Cellular Biology.
[4] Hong Yang,et al. Phosphorylation of p53 on Key Serines Is Dispensable for Transcriptional Activation and Apoptosis*♦ , 2004, Journal of Biological Chemistry.
[5] K. Khalili,et al. Interplay between HIV-1 Vpr and Sp1 Modulates p21WAF1 Gene Expression in Human Astrocytes* , 2004, Journal of Biological Chemistry.
[6] Joonhee Kim,et al. Modification of serine 392 is a critical event in the regulation of p53 nuclear export and stability , 2004, FEBS letters.
[7] X. Graña,et al. Cellular control of gene expression by T-type cyclin/CDK9 complexes. , 2004, Gene.
[8] A. Rice,et al. Human Immunodeficiency Virus Type 1 Infection Induces Cyclin T1 Expression in Macrophages , 2004, Journal of Virology.
[9] Xin Lu,et al. Ser392 Phosphorylation Regulates the Oncogenic Function of Mutant p53 , 2004, Cancer Research.
[10] Patrick Dowd,et al. The ubiquitin ligase COP1 is a critical negative regulator of p53 , 2004, Nature.
[11] C. Harris,et al. p53: 25 years after its discovery. , 2004, Trends in pharmacological sciences.
[12] Guillermina Lozano,et al. MDM2, an introduction. , 2003, Molecular cancer research : MCR.
[13] Takashi Okamoto,et al. c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis , 2003, Oncogene.
[14] A. L. Okorokov. p53 in a Crosstalk Between DNA Repair and Cell Cycle Checkpoints , 2003, Cell cycle.
[15] G. Melino,et al. p53: 25 years of research and more questions to answer , 2003, Cell Death and Differentiation.
[16] Guillermina Lozano,et al. Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation , 2003, Cell.
[17] S. Shuman,et al. Interactions between Fission Yeast Cdk9, Its Cyclin Partner Pch1, and mRNA Capping Enzyme Pct1 Suggest an Elongation Checkpoint for mRNA Quality Control* , 2003, The Journal of Biological Chemistry.
[18] M. Oren,et al. The p53-Mdm2 module and the ubiquitin system. , 2003, Seminars in cancer biology.
[19] A. Giordano,et al. Cdk9, a member of the cdc2-like family of kinases, binds to gp130, the receptor of the IL-6 family of cytokines , 2002, Oncogene.
[20] A. Giordano,et al. Interplay between cdk9 and NF-κB factors determines the level of HIV-1 gene transcription in astrocytic cells , 2002, Oncogene.
[21] A. Giordano,et al. Physical interaction between pRb and cdk9/cyclinT2 complex , 2002, Oncogene.
[22] Z. Ronai,et al. p53-Mdm2--the affair that never ends. , 2002, Carcinogenesis.
[23] G. Johnson,et al. Cdk5 phosphorylates p53 and regulates its activity , 2002, Journal of neurochemistry.
[24] T. Shono,et al. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation. , 2002, Cancer research.
[25] D. Meek. p53 Induction: Phosphorylation Sites Cooperate in Regulating Interatction , 2002, Cancer biology & therapy.
[26] P. Farnham,et al. Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. , 2002, Methods.
[27] K. Vousden,et al. Activation and activities of the p53 tumour suppressor protein , 2001, British Journal of Cancer.
[28] Tamás Kiss,et al. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes , 2001, Nature.
[29] J. Karn,et al. Activation of Human Immunodeficiency Virus Transcription in T Cells Revisited: NF-κB p65 Stimulates Transcriptional Elongation , 2001, Journal of Virology.
[30] A. Giordano,et al. New insight in cdk9 function: from Tat to MyoD. , 2001, Frontiers in bioscience : a journal and virtual library.
[31] M. Clarke,et al. Regulation of p53 localization. , 2001, European journal of biochemistry.
[32] S. T. Kim,et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. , 2001, Genes & development.
[33] Chawnshang Chang,et al. Androgen Receptor Interacts with the Positive Elongation Factor P-TEFb and Enhances the Efficiency of Transcriptional Elongation* , 2001, The Journal of Biological Chemistry.
[34] A. Rice,et al. Antiapoptotic Function of Cdk9 (TAK/P-TEFb) in U937 Promonocytic Cells , 2001, Journal of Virology.
[35] M. Kapoor,et al. A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. , 2001, Molecular cell.
[36] K. Khalili,et al. Cooperative Interaction between HIV-1 Regulatory Proteins Tat and Vpr Modulates Transcription of the Viral Genome* , 2000, The Journal of Biological Chemistry.
[37] E. Sausville,et al. Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication* , 2000, The Journal of Biological Chemistry.
[38] A. Rice,et al. Genomic organization and characterization of promoter function of the human CDK9 gene. , 2000, Gene.
[39] Shengyun Fang,et al. Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53* , 2000, The Journal of Biological Chemistry.
[40] A. Giordano,et al. Physical interaction between CDK9 and B-Myb results in suppression of B-Myb gene autoregulation , 2000, Oncogene.
[41] Junmin Peng,et al. Cyclin K Functions as a CDK9 Regulatory Subunit and Participates in RNA Polymerase II Transcription* , 1999, The Journal of Biological Chemistry.
[42] A. Giordano,et al. Transcriptional regulation by targeted recruitment of cyclin-dependent CDK9 kinase in vivo , 1999, Oncogene.
[43] M. Kapoor,et al. The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53. , 1999, Biochemical and biophysical research communications.
[44] J. Karn,et al. Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation. , 1999, Journal of molecular biology.
[45] M. Mathews,et al. Human and Rodent Transcription Elongation Factor P-TEFb: Interactions with Human Immunodeficiency Virus Type 1 Tat and Carboxy-Terminal Domain Substrate , 1999, Journal of Virology.
[46] Weiya Ma,et al. p38 Kinase Mediates UV-induced Phosphorylation of p53 Protein at Serine 389* , 1999, The Journal of Biological Chemistry.
[47] M. Kubbutat,et al. Regulation of p53 Function and Stability by Phosphorylation , 1999, Molecular and Cellular Biology.
[48] A. Giordano,et al. Binding of CDK9 to TRAF2 , 1998, Journal of cellular biochemistry.
[49] M. Garber,et al. The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. , 1998, Genes & development.
[50] V. Adler,et al. Mdm2 association with p53 targets its ubiquitination , 1998, Oncogene.
[51] K. Khalili,et al. Cooperative Actions of HIV-1 Vpr and p53 Modulate Viral Gene Transcription* , 1998, The Journal of Biological Chemistry.
[52] J. Milton,et al. Identification of multiple cyclin subunits of human P-TEFb. , 1998, Genes & development.
[53] D. Hazuda,et al. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. , 1997, Genes & development.
[54] A. Levine,et al. The CDK7-cycH-p36 complex of transcription factor IIH phosphorylates p53, enhancing its sequence-specific DNA binding activity in vitro , 1997, Molecular and cellular biology.
[55] H. Sakamoto,et al. Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. , 1997, Biochemistry.
[56] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[57] D. Price,et al. Control of RNA Polymerase II Elongation Potential by a Novel Carboxyl-terminal Domain Kinase* , 1996, The Journal of Biological Chemistry.
[58] X. Graña,et al. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). , 1995, Oncogene.
[59] M. Fiscella,et al. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities. , 1994, Oncogene.
[60] A. Giordano,et al. PITALRE, a nuclear CDC2-related protein kinase that phosphorylates the retinoblastoma protein in vitro. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[61] D. Lane,et al. Regulation of the specific DNA binding function of p53 , 1992, Cell.
[62] C. Delphin,et al. Casein kinase II and the tumor suppressor protein P53 associate in a molecular complex that is negatively regulated upon P53 phosphorylation. , 1992, The Journal of biological chemistry.
[63] D. Meek,et al. The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II. , 1990, The EMBO journal.
[64] B. Gusterson,et al. Ser 392 Phosphorylation Regulates the Oncogenic Function of Mutant p 53 , 2004 .
[65] M. Clarke,et al. Regulation of p 53 localization , 2001 .
[66] A. Rice,et al. Antiapoptotic Function of Cdk 9 ( TAK / P-TEFb ) in U 937 Promonocytic Cells , 2000 .